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Case Report
AbstractCarcinoma of oropharynx generally metastasizes to lungs, liver and bone whileretroperitoneal and pelvic metastasis is very rare. We hereby report anextremely rare and unusual case of retroperitoneal and pelvic metastasis fromsquamous cell carcinoma of vallecula. To the best of our knowledge, this case isone of the scantly reported cases of this kind in the world. A 60-year-old malepresented with complaints of dysphagia and hoarseness of voice of four monthsduration. Clinical evaluation and computed tomography scan of face and neckshowed growth right vallecula and a biopsy revealed squamous cell carcinoma.Metastatic work up was negative. We treated him with definitivechemo-radiation, which he tolerated well. During follow up, he presented withdyspepsia, abdominal discomfort and weight loss. Whole body positron emissiontomography scan revealed disseminated retroperitoneal and pelvic lymph nodedeposits, which were confirmed as metastasis of squamous cell carcinoma onimage guided fine needle aspiration cytology. Patient was exhibited palliativechemotherapy in view of extensive metastasis. However, his general conditiondeteriorated and he finally succumbed to his illness. The aim of this case is tohighlight the extreme rarity, the diagnostic and therapeutic challenges  and theoverall dismal prognosis of this condition.
Keywords: Metastasis; Pelvic lymph nodes; Retroperitoneum; Squamous cellcarcinoma; Vallecula
1. IntroductionDistant metastatic spread from oropharyngeal cancer orany head and neck malignancy is relatively uncommon.It affects approximately 15 % of all patients during thecourse of disease.1 The most common sites for distantmetastasis are lung, bone, and liver1 while distantmetastasis without local recurrence is much rarer.2Carcinoma oropharynx metastasizing toretroperitoneum and pelvic lymph nodes is the lastdiagnosis which could be thought of for a 60-year-oldmale patient presenting with dyspepsia and abdominaldiscomfort. A high degree of clinical suspicion isrequired to diagnose this condition. Retroperitonealspread can occur with cancers of the pancreas, breast,cervix, endometrium, kidney, colon or prostate whilepelvic lymphatic spread is generally from penile andtesticular carcinomas. Our case is one such sporadic andunusual presentation where carcinoma of vallecula afterdefinitive treatment with concurrent chemo-radiotherapy (CCRT) metastasized directly to
retroperitoneum and pelvis without involvement of itscommon metastatic sites with the primary disease undercontrol.
2. Case PresentationA 60-year-old male with no known comorbiditiespresented with history of progressive dysphagia andhoarseness of voice of four months duration. Patient wasa chronic tobacco smoker for past 40 years. Hishematological and biochemical parameters were withinnormal limits. Clinical evaluation revealed a 5 × 4 cmulcero-proliferative lesion involving right valleculla withno evidence of palpable neck nodes. Tissue biopsy fromthe lesion (Figure 1) revealed a moderatelydifferentiated squamous cell carcinoma. Computedtomography (CT) scan of face and neck (Figure 2)showed a mass lesion measuring 2.4 × 2.2 × 3.4 cmepicentered in right vallecula involving base of tonguewith multiple necrotic lymph nodes on ipsilateral side
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largest 1.4 cm right level II. Whole body positronemission tomography (WB PET) scan showed a 3 × 3.2 ×5 cm soft tissue thickening in oropharynx with multiplelymph nodes involving bilateral neck. Patient was stagedas cT3N2cM0 Stage IVA. We treated him withdefinitive radiotherapy by 3-dimensional conformalradiation therapy (3-DCRT) technique to a dose of 70Gray (Gy) in 35 fractions along with concurrentchemotherapy inj cisplatin. Patient tolerated treatmentwell and was on regular follow up, but after six months,he presented with dyspepsia, abdominal discomfort andweight loss. An upper gastro-intestinal endoscopy(UGIE) was essentially normal. No evidence of anyresidual or recurrent disease was seen on localevaluation. WB PET scan showed complete metabolicresolution of primary lesion as well as pre-existinglymph nodes, however increased fluoro-deoxy-glucose(FDG) uptake was noted in retroperitoneal lymph nodeslike porto-caval, pre-aortic, aorto-caval lymph nodes(Figure 3) and in right common iliac lymph nodes(Figure 4). CT guided FNAC from retroperitoneal andpelvic deposits revealed metastasis of squamous cellcarcinoma (Figure 5). Patient was diagnosed as a case ofcarcinoma vallecula with retroperitoneal and pelvicmetastasis and was managed with palliativechemotherapy inj paclitaxel, carboplatin and cetuximab.However, during treatment, his general conditiondeteriorated and chemotherapy was inadvertentlystopped. He was thereafter kept on supportive care butfinally succumbed to his metastatic disease.
Figure 1: Tissue biopsy from vallecula showing moderatelydifferentiated squamous cell carcinoma (H & E 100 X).
Figure 2: CT scan face and neck showing a mass lesion inright vallecula (yellow arrow).
Figure 3: WB PET scan showing increased FDG uptakein retroperitoneal lymph nodes.
Figure 4: WB PET scan showing increased FDG uptakein right common iliac lymph nodes.
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Figure 5: CT guided FNAC from retroperitoneal andpelvic deposits showing metastasis of squamous cellcarcinoma (H & E 40 X).
3. DiscussionThe incidence of distant metastasis from head and neckcarcinomas was less than one percent as was firstreported in 1906 by Crile.3 . However, there is a trendin rise of distant metastasis from head and neckmalignancies in the present scenario of highly advanceddiagnostic and curative modalities. It is probablybecause metastasis has become more evident in patientswho survive longer than their usual life span.4 Distantmetastasis in oropharyngeal carcinomas are morecommon in patients presenting with advancedlocoregional and recurrent lesions, the risk increasingwith tumor stage, size and lymphadenopathy i.e., N2 orN3 disease.1,5 Other important risk factors areinvolvement of level IV cervical lymph nodes,lymphovascular invasion and extranodal extension.6Involvement of the retroperitoneum can occur mostcommonly by haematogenous dissemination whiledirect invasion, lymphatic spread and intraperitonealseeding from exfoliated cancer cells are other modes ofspread.7 Pelvic spread is mostly from lymphatic route.8Patients with retroperitoneal metastasis usually remainasymptomatic. However, they may present withcomplaints of nausea, vomiting, abdominal discomfort,distension, pain, backache, frequency of urination,lymphedema or hydronephrosis.7 The most commonsites of distant metastasis from oropharyngealcarcinoma are pulmonary parenchyma followed by boneand liver while metastasis to retroperitoneum and pelviclymph nodes  is extremely uncommon and has rarelybeen reported or written in standard oncologytextbooks.1 Retroperitoneal metastasis generally haveprimaries from carcinoma ovary,,gastric carcinoma,colorectal carcinoma, carcinoma lung, peritonealmalignancy, carcinoma breast, testicular carcinomas andeven frommalignant melanomas7,9 while common iliac
lymph node metastasis have primaries from penis andtestis8 but not from head and neck malignancies.Differential diagnosis of retroperitoneal deposits can beperitoneal tuberculosis, peritoneal mesothelioma,benign calcifications or abdominal sepsis, but in all thesecases, a primary tumor is not known.Radiographic modalities like ultrasonography (USG), CTscan, magnetic resonance imaging (MRI) and PET scanhelp to distinguish these peritoneal and pelvicpathologies from metastatic lesion. CT scan can detectperitoneal metastasis in 85-93% cases7and they appearas soft tissue nodules, enhancement of peritonealreflections, thickening of omentum or omental caking,distortion of mesentery, calcifications and ascites. MRIhas proved to be more sensitive than CT scan indetection of metastatic lesions7 while PET imagingevaluates the biochemical and physiologicalcharacteristics of tumor cells, generating a radiographicpicture of metabolic activity from the cancer nodule thatis not possible with CT or MRI. These imagingtechniques generally use lymph node size as the criteriafor differentiating metastatic and benign lesions. Lymphnodes with a short-axis diameter more than 5 mm in theretroperitoneum and 6 mm in the pelvis are consideredabnormal.9 The novel procedures of intraperitonealcontrast CT,10 lymphotropic nanoparticle enhancedMRI,8 diffusion-weighted MRI8 and C-cholin PET scan8are being used as a way to improve sensitivity ofdetection of retroperitoneal and pelvic metastasis.Regarding treatment, few studies in literature existmainly from metastatic ovarian carcinomas andtesticular carcinomas. Presently there are no definiteguidelines for treatment of retroperitoneal or pelvicmetastasis from carcinoma of oropharynx and themetastasis per se are not locally treated by surgery orradiotherapy, although systemic treatment withpalliative chemotherapy may have some effect. Whileselecting therapy, overall survival should be taken intoconsideration. Complications like malignant ascites orbowel obstruction do however frequently requiretreatment for palliation. In our institute we usedparenteral chemotherapeutic agents like paclitaxel,carboplatin and cetuximab a monoclonal antibody andan epidermal growth factor receptor (EGFR) inhibitor inour patient, though he was not able to complete theplanned chemotherapy due to his deteriorating generalcondition and we were not able to establish its effect onoverall survival of the patient.
4. ConclusionThe aim of reporting this case is to highlight its extremerarity, mode of presentation, high degree of clinicalsuspicion required in detecting such an uncommonentity, multimodality treatment exhibited and theoverall prognosis. The diagnosis of retroperitonealmetastasis should always be considered whenever anypatient earlier treated for oropharyngeal carcinoma
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presents with vague abdominal discomfort or weightloss  to enable a prompt initiation of appropriatetreatment. Extensive retroperitoneal metastasis isknown as peritoneal carcinomatosis which indicates adismal prognosis and poor survival. Due to lack of anydefinitive management protocol and scarcity of relevantliterature for retroperitoneal and pelvic metastasis fromcarcinoma of oropharynx, we recommend more studies,trials, case reports and researches on functional imagingmodalities to be done in order to establish an acceptabletreatment guideline for such disease.
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